MedPath

PROMOMED TOV

🇺🇦Ukraine
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:10

Trial Phases

2 Phases

Phase 3:6
Phase 4:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Phase 3
6 (66.7%)
Phase 4
3 (33.3%)

Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19

Phase 4
Completed
Conditions
Functional MRI
Cognitive Impairment
Asthenia
COVID-19
Interventions
Other: Structural and functional MRI
Drug: Ethyl methyl hydroxypyridine succinate + Meldonium
Drug: Placebo
First Posted Date
2023-07-11
Last Posted Date
2023-07-13
Lead Sponsor
Promomed, LLC
Target Recruit Count
30
Registration Number
NCT05939622
Locations
🇷🇺

Federal State Budgetary Research Institution "Research Centre of Neurology", Moscow, Russian Federation

Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

Phase 4
Completed
Conditions
Obesity
Interventions
First Posted Date
2023-04-20
Last Posted Date
2023-04-24
Lead Sponsor
Promomed, LLC
Target Recruit Count
240
Registration Number
NCT05821543
Locations
🇷🇺

Ivanovo Clinical Hospital named after Kuvaev, Ivanovo, Russian Federation

🇷🇺

Kirov State Medical University, Kirov, Russian Federation

🇷🇺

Pirogov Russian National Research Medical University, Moscow, Russian Federation

and more 5 locations

Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

Phase 3
Completed
Conditions
COVID-19
Interventions
First Posted Date
2023-02-10
Last Posted Date
2023-02-16
Lead Sponsor
Promomed, LLC
Target Recruit Count
800
Registration Number
NCT05722691
Locations
🇷🇺

Regional Budgetary Healthcare Institution Ivanovo Clinical Hospital, Ivanovo, Russian Federation

🇷🇺

Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of Ministry of Health of the Russian Federation, Kirov, Russian Federation

🇷🇺

State Budgetary Healthcare Institution of Moscow Municipal Clinical Hospital Named after S. I. Spasokukotsky of Moscow Healthcare Department, Moscow, Russian Federation

and more 7 locations

Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19

Phase 4
Completed
Conditions
Asthenia
COVID-19
Interventions
Drug: Ethyl methyl hydroxypyridine succinate + Meldonium
Drug: Placebo
First Posted Date
2023-01-19
Last Posted Date
2023-07-13
Lead Sponsor
Promomed, LLC
Target Recruit Count
160
Registration Number
NCT05689827
Locations
🇷🇺

Federal State Budgetary Research Institution "Research Centre of Neurology", Moscow, Russian Federation

🇷🇺

OsteoVita LLC, Saint Petersburg, Russian Federation

🇷🇺

Saint Petersburg State Budgetary Healthcare Institution "Municipal Hospital No. 40 of Kurortny District", Sestroretsk, Russian Federation

and more 3 locations

Efficacy and Safety of Ambervin® and Standard Therapy in Hospitalized Patients With COVID-19

Phase 3
Completed
Conditions
COVID-19
Interventions
Drug: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate inhaled
Drug: Standard of care
Drug: Tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine succinate intramuscularly
First Posted Date
2022-12-19
Last Posted Date
2023-04-06
Lead Sponsor
Promomed, LLC
Target Recruit Count
313
Registration Number
NCT05656495
Locations
🇷🇺

Budgetary institution of the Chuvash Republic "Emergency Hospital", Cheboksary, Russian Federation

🇷🇺

City clinical Hospital №24, Moscow, Russian Federation

🇷🇺

Infectious Clinical Hospital No.1, Moscow, Russian Federation

and more 7 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.